Final Deadline for the AstraZeneca PLC Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - AZN

20.02.25 21:56 Uhr

Werte in diesem Artikel
Aktien

142,45 EUR 1,80 EUR 1,28%

LOS ANGELES, Feb. 20, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ: AZN) for violations of the federal securities laws.

DJS Law Group

Shareholders who purchased the Company's securities between February 23, 2022 and December 17, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 21, 2025.

CASE DETAILS: The Company allegedly made false and misleading statements to the market regarding taking part in insurance fraud in China. The Company faced significant legal exposure in China, eventually resulting in its China President being detained by law enforcement.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

 Eastchester, NY 10709

Phone: 914-206-9742

Email: David@djslawllp.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/final-deadline-for-the-astrazeneca-plc-securities-lawsuit---contact-the-djs-law-group-to-discuss-your-rights---azn-302381692.html

SOURCE DJS Law Group LLP

Ausgewählte Hebelprodukte auf AstraZeneca

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf AstraZeneca

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu AstraZeneca PLC

Wer­bung

Analysen zu AstraZeneca PLC

DatumRatingAnalyst
20.02.2025AstraZeneca OutperformBernstein Research
19.02.2025AstraZeneca OverweightJP Morgan Chase & Co.
13.02.2025AstraZeneca BuyUBS AG
12.02.2025AstraZeneca HoldDeutsche Bank AG
11.02.2025AstraZeneca OutperformBernstein Research
DatumRatingAnalyst
20.02.2025AstraZeneca OutperformBernstein Research
19.02.2025AstraZeneca OverweightJP Morgan Chase & Co.
13.02.2025AstraZeneca BuyUBS AG
11.02.2025AstraZeneca OutperformBernstein Research
10.02.2025AstraZeneca BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
12.02.2025AstraZeneca HoldDeutsche Bank AG
07.02.2025AstraZeneca HaltenDZ BANK
07.02.2025AstraZeneca HoldDeutsche Bank AG
06.02.2025AstraZeneca NeutralUBS AG
06.02.2025AstraZeneca HoldJefferies & Company Inc.
DatumRatingAnalyst
12.11.2024AstraZeneca SellUBS AG
07.11.2024AstraZeneca SellUBS AG
05.11.2024AstraZeneca SellUBS AG
05.11.2024AstraZeneca SellDeutsche Bank AG
05.11.2024AstraZeneca SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für AstraZeneca PLC nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"